Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study

Fig. 1

Experimental design for the high-precision LC-MS proteomic discovery analysis, data reduction and subsequent targeted validation pipeline. BrCA breast cancer, ELISA enzyme-linked immunosorbent assay, BMI body mass index, LN lymph node, ER oestrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2

Back to article page